| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 75, 367-369, Copyright © 1992 by Endocrine Society
ARTICLES |
DJ Kennaway, GE Stamp and FC Goble
Department of Obstetrics and Gynaecology, University of Adelaide, South Australia.
The development of rhythmic 6-sulfatoxymelatonin excretion in urine was studied in healthy full-term and premature infants during the first 12 months of life. There was little evidence of rhythmic 6- sulfatoxymelatonin excretion before 9 to 12 weeks of age in full-term infants. Over this period, excretion increased five to six times compared to the excretion at 6 weeks (08 +/- 103 vs. 2973 +/- 438 pmol/24 h) with the major proportion of the hormone metabolite being excreted between 0200-1000 h. At 24 weeks of age, total 6- sulfatoxymelatonin excretion was 25% of adult levels. Premature infants (51 +/- 4 days premature) had a delay in the appearance of rhythmic 6- sulfatoxymelatonin of approximately 9 weeks. Even after correcting for gestational age or length of time at home, the premature infants were found to have a 2-3 week delay in the development of 6- sulfatoxymelatonin rhythmicity compared to full-term infants. These results provide evidence that neural centers responsible for rhythm generation and/or the pineal gland fail to accelerate their development after premature delivery. This may be due to the environment the infants are exposed to during their stay in hospital, particularly the pattern and intensity of lighting.
This article has been cited by other articles:
![]() |
C. Torres-Farfan, V. Rocco, C. Monso, F. J. Valenzuela, C. Campino, A. Germain, F. Torrealba, G. J. Valenzuela, and M. Seron-Ferre Maternal Melatonin Effects on Clock Gene Expression in a Nonhuman Primate Fetus Endocrinology, October 1, 2006; 147(10): 4618 - 4626. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Mornson, D. W. Rurak, C. Chien, D. J. Kennaway, N. Gruber, I. C. McMillen, and K. W. Riggs Maternal Fluoxetine Infusion Does Not Alter Fetal Endocrine and Biophysical Circadian Rhythms in Pregnant Sheep Reproductive Sciences, July 1, 2005; 12(5): 356 - 364. [Abstract] [PDF] |
||||
![]() |
C. Torres-Farfan, H. G. Richter, A. M. Germain, G. J. Valenzuela, C. Campino, P. Rojas-Garcia, M. L. Forcelledo, F. Torrealba, and M. Seron-Ferre Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland J. Physiol., February 1, 2004; 554(3): 841 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Rivkees Developing Circadian Rhythmicity in Infants Pediatrics, August 1, 2003; 112(2): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Davis Melatonin: Role in Development J Biol Rhythms, December 1, 1997; 12(6): 498 - 508. [Abstract] [PDF] |
||||
![]() |
I. V Zhdanova and R. J. Wurtman Efficacy of Melatonin as a Sleep-Promoting Agent J Biol Rhythms, December 1, 1997; 12(6): 644 - 650. [Abstract] [PDF] |
||||
![]() |
S. A. Rivkees, P. L. Hofman, and J. Fortman Newborn primate infants are entrained by low intensity lighting PNAS, January 7, 1997; 94(1): 292 - 297. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |